Main anti-inflammatory properties of HDLs
Main anti-inflammatory properties of HDLs. “↗” means “increase”. Several mediators promote the inflammatory NF-κB pathway in vascular cells, including endoplasmic reticulum (ER) stress, TNF-α, AGEs, ROS, and modified LDLs. This results in an elevated gene expression of adhesion molecules, pro-inflammatory cytokines, and NADPH oxidase (NOX2). (1) Healthy HDLs bind to S1P receptors (S1PR), SR-BI, ABCA1 and ABCG1. (2) HDL-mediated protection of LDLs against oxidation counteracts the activating effect of oxidized LDLs on NF-κB pathway through the binding to the LOX-1 receptor. (3) HDLs dampen ROS production. (4) The activation of endothelial NO synthase by HDLs leads to the inhibiting nitrosylation of NF-κB. (5) Ultimately, HDLs have the capacity to impede the translocation of NF-κB into the nucleus, (6) subsequently suppressing the gene expression of pro-inflammatory cytokines and adhesion molecules. (7) Such transcriptional effects inhibit the recruitment of immune cells into the subendothelial space. The figure was partly created utilizing Servier Medical Art (Creative Commons Attribution 3.0 unported license)
Publication
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes (2024) Damien Denimal, et al. Antioxidants (Basel). 2024 Jan;13(1). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TNF-α | TNF | ncbigene_symbol | TNF | 7124 |
| Homo sapiens | Primates | HDLS | HDLS | ncbigene_synonym | CSF1R | 1436 |
| Homo sapiens | Primates | TNFR | TNFR | ncbigene_synonym | TNFRSF1A | 7132 |
| Homo sapiens | Primates | RAGE | RAGE | ncbigene_synonym | AGER | 177 |
| Homo sapiens | Primates | RAGE | RAGE | ncbigene_synonym | MOK | 5891 |
| Homo sapiens | Primates | LOX-1 | LOX1 | ncbigene_synonym | OLR1 | 4973 |
| Homo sapiens | Primates | SR-B1 | SRB1 | ncbigene_synonym | SCARB1 | 949 |
| Homo sapiens | Primates | ABC | ABC | ncbigene_synonym | ABCB6 | 10058 |
| Homo sapiens | Primates | S1PR | S1PR | famplex_relations | S1PR1 | 1901 |
| Homo sapiens | Primates | S1PR | S1PR | famplex_relations | S1PR2 | 9294 |
| Homo sapiens | Primates | S1PR | S1PR | famplex_relations | S1PR3 | 1903 |
| Homo sapiens | Primates | S1PR | S1PR | famplex_relations | S1PR4 | 8698 |
| Homo sapiens | Primates | S1PR | S1PR | famplex_relations | S1PR5 | 53637 |
| Homo sapiens | Primates | A1/G1 | A1 | ncbigene_synonym | ADRA1D | 146 |
| Homo sapiens | Primates | A1/G1 | AG1 | ncbigene_synonym | TXNDC12 | 51060 |
| Homo sapiens | Primates | A1/G1 | AG1 | ncbigene_synonym | NBPF10 | 100132406 |
| Homo sapiens | Primates | (IKK) | IKK | famplex_relations | CHUK | 1147 |
| Homo sapiens | Primates | (IKK) | IKK | famplex_relations | IKBKB | 3551 |
| Homo sapiens | Primates | (IKK) | IKK | famplex_relations | IKBKG | 8517 |
| Homo sapiens | Primates | (IKK) | IKK | famplex_relations | IKBKE | 9641 |
| Homo sapiens | Primates | (IKK) | IKK | famplex_relations | TBK1 | 29110 |
| Homo sapiens | Primates | -NF-kB | NFKB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | -NF-kB | NFKB | famplex_relations | RELA | 5970 |
| Homo sapiens | Primates | -NF-kB | NFKB | famplex_relations | RELB | 5971 |
| Homo sapiens | Primates | -NF-kB | NFKB | famplex_relations | REL | 5966 |
| Homo sapiens | Primates | -NF-kB | NFKB | famplex_relations | NFKB2 | 4791 |
| Homo sapiens | Primates | VCAM-1, | VCAM1 | ncbigene_symbol | VCAM1 | 7412 |
| Homo sapiens | Primates | ICAM-1, | ICAM1 | ncbigene_symbol | ICAM1 | 3383 |
| Homo sapiens | Primates | CCL-2 | CCL2 | ncbigene_symbol | CCL2 | 6347 |
| Homo sapiens | Primates | NOX2 | NOX2 | ncbigene_synonym | CYBB | 1536 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| AGES | AGEs | chebi:84123 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| hyperglycemia | hyperglycemia | hyperglycemia | DOID:4195 |